Medical - Devices
Compare Stocks
4 / 10Stock Comparison
QTRX vs DBVT vs ALKS vs SEER
Revenue, margins, valuation, and 5-year total return — side by side.
Biotechnology
Biotechnology
Biotechnology
QTRX vs DBVT vs ALKS vs SEER — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Medical - Devices | Biotechnology | Biotechnology | Biotechnology |
| Market Cap | $129M | $1712.35T | $5.90B | $105M |
| Revenue (TTM) | $145M | $0.00 | $1.56B | $16M |
| Net Income (TTM) | $-104M | $-168M | $153M | $-79M |
| Gross Margin | 44.1% | — | 65.4% | 40.7% |
| Operating Margin | -96.4% | — | 12.3% | -5.2% |
| Forward P/E | — | — | 24.8x | — |
| Total Debt | $37M | $22M | $70M | $26M |
| Cash & Equiv. | $30M | $194M | $1.12B | $41M |
QTRX vs DBVT vs ALKS vs SEER — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Dec 20 | May 26 | Return |
|---|---|---|---|
| Quanterix Corporati… (QTRX) | 100 | 5.9 | -94.1% |
| DBV Technologies S.… (DBVT) | 100 | 76.3 | -23.7% |
| Alkermes plc (ALKS) | 100 | 177.4 | +77.4% |
| Seer, Inc. (SEER) | 100 | 3.3 | -96.7% |
Price return only. Dividends and distributions are not included.
Quick Verdict: QTRX vs DBVT vs ALKS vs SEER
Each card shows where this stock fits in a portfolio — not just who wins on paper.
QTRX is the #2 pick in this set and the best alternative if growth is your priority.
- 2.6% revenue growth vs DBVT's -100.0%
DBVT is the clearest fit if your priority is income & stability.
- Dividend streak 0 yrs, beta 1.26
- +110.4% vs QTRX's -48.7%
ALKS carries the broadest edge in this set and is the clearest fit for long-term compounding.
- -11.0% 10Y total return vs DBVT's -87.0%
- 9.8% margin vs SEER's -486.0%
- 5.4% ROA vs DBVT's -89.0%
SEER is the clearest fit if your priority is growth exposure and sleep-well-at-night.
- Rev growth -8.1%, EPS growth -3.0%, 3Y rev CAGR 29.7%
- Lower volatility, beta 0.84, Low D/E 7.9%, current ratio 16.53x
- Beta 0.84, current ratio 16.53x
- Beta 0.84 vs QTRX's 1.98, lower leverage
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 2.6% revenue growth vs DBVT's -100.0% | |
| Quality / Margins | 9.8% margin vs SEER's -486.0% | |
| Stability / Safety | Beta 0.84 vs QTRX's 1.98, lower leverage | |
| Dividends | Tie | None of these 4 stocks pay a meaningful dividend |
| Momentum (1Y) | +110.4% vs QTRX's -48.7% | |
| Efficiency (ROA) | 5.4% ROA vs DBVT's -89.0% |
QTRX vs DBVT vs ALKS vs SEER — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
QTRX vs DBVT vs ALKS vs SEER — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
ALKS leads in 2 of 6 categories
SEER leads 1 • QTRX leads 0 • DBVT leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
ALKS leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ALKS and DBVT operate at a comparable scale, with $1.6B and $0 in trailing revenue. ALKS is the more profitable business, keeping 9.8% of every revenue dollar as net income compared to SEER's -4.9%. On growth, ALKS holds the edge at +28.2% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $145M | $0 | $1.6B | $16M |
| EBITDAEarnings before interest/tax | -$125M | -$112M | $212M | -$76M |
| Net IncomeAfter-tax profit | -$104M | -$168M | $153M | -$79M |
| Free Cash FlowCash after capex | -$83M | -$151M | $392M | -$46M |
| Gross MarginGross profit ÷ Revenue | +44.1% | — | +65.4% | +40.7% |
| Operating MarginEBIT ÷ Revenue | -96.4% | — | +12.3% | -5.2% |
| Net MarginNet income ÷ Revenue | -71.9% | — | +9.8% | -4.9% |
| FCF MarginFCF ÷ Revenue | -57.2% | — | +25.1% | -2.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | +20.3% | — | +28.2% | +4.5% |
| EPS Growth (YoY)Latest quarter vs prior year | +30.2% | +91.5% | -4.1% | +8.6% |
Valuation Metrics
SEER leads this category, winning 2 of 3 comparable metrics.
Valuation Metrics
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $129M | $1712.35T | $5.9B | $105M |
| Enterprise ValueMkt cap + debt − cash | $136M | $1712.35T | $4.9B | $90M |
| Trailing P/EPrice ÷ TTM EPS | -1.10x | -0.76x | 24.76x | -1.35x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | — | — |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — |
| EV / EBITDAEnterprise value multiple | — | — | 17.25x | — |
| Price / SalesMarket cap ÷ Revenue | 0.93x | — | 4.00x | 7.52x |
| Price / BookPrice ÷ Book value/share | 0.40x | 0.66x | 3.28x | 0.36x |
| Price / FCFMarket cap ÷ FCF | — | — | 12.28x | — |
Profitability & Efficiency
ALKS leads this category, winning 8 of 9 comparable metrics.
Profitability & Efficiency
ALKS delivers a 8.8% return on equity — every $100 of shareholder capital generates $9 in annual profit, vs $-130 for DBVT. ALKS carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to DBVT's 0.13x. On the Piotroski fundamental quality scale (0–9), ALKS scores 7/9 vs QTRX's 2/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | -35.2% | -130.2% | +8.8% | -29.2% |
| ROA (TTM)Return on assets | -26.0% | -89.0% | +5.4% | -25.7% |
| ROICReturn on invested capital | -21.4% | — | +18.9% | -21.3% |
| ROCEReturn on capital employed | -24.7% | -145.7% | +14.2% | -25.9% |
| Piotroski ScoreFundamental quality 0–9 | 2 | 4 | 7 | 4 |
| Debt / EquityFinancial leverage | 0.13x | 0.13x | 0.04x | 0.08x |
| Net DebtTotal debt minus cash | $7M | -$172M | -$1.0B | -$15M |
| Cash & Equiv.Liquid assets | $30M | $194M | $1.1B | $41M |
| Total DebtShort + long-term debt | $37M | $22M | $70M | $26M |
| Interest CoverageEBIT ÷ Interest expense | — | -189.82x | 32.30x | — |
Total Returns (Dividends Reinvested)
Evenly matched — DBVT and ALKS each lead in 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ALKS five years ago would be worth $16,091 today (with dividends reinvested), compared to $490 for QTRX. Over the past 12 months, DBVT leads with a +110.4% total return vs QTRX's -48.7%. The 3-year compound annual growth rate (CAGR) favors DBVT at 6.2% vs QTRX's -45.8% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | -57.2% | +4.9% | +25.3% | +3.3% |
| 1-Year ReturnPast 12 months | -48.7% | +110.4% | +16.5% | +1.6% |
| 3-Year ReturnCumulative with dividends | -84.1% | +19.7% | +14.5% | -47.2% |
| 5-Year ReturnCumulative with dividends | -95.1% | -69.1% | +60.9% | -95.1% |
| 10-Year ReturnCumulative with dividends | -84.3% | -87.0% | -11.0% | -96.7% |
| CAGR (3Y)Annualised 3-year return | -45.8% | +6.2% | +4.6% | -19.2% |
Risk & Volatility
Evenly matched — ALKS and SEER each lead in 1 of 2 comparable metrics.
Risk & Volatility
SEER is the less volatile stock with a 0.84 beta — it tends to amplify market swings less than QTRX's 1.98 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ALKS currently trades 96.7% from its 52-week high vs QTRX's 31.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.98x | 1.26x | 1.06x | 0.84x |
| 52-Week HighHighest price in past year | $8.77 | $26.18 | $36.60 | $2.41 |
| 52-Week LowLowest price in past year | $2.56 | $7.53 | $25.17 | $1.65 |
| % of 52W HighCurrent price vs 52-week peak | +31.4% | +76.3% | +96.7% | +78.0% |
| RSI (14)Momentum oscillator 0–100 | 42.3 | 48.1 | 60.2 | 49.8 |
| Avg Volume (50D)Average daily shares traded | 937K | 252K | 2.3M | 401K |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Analyst consensus: QTRX as "Buy", DBVT as "Buy", ALKS as "Buy", SEER as "Hold". Consensus price targets imply 131.8% upside for DBVT (target: $46) vs 24.3% for ALKS (target: $44).
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Hold |
| Price TargetConsensus 12-month target | $4.00 | $46.33 | $44.00 | — |
| # AnalystsCovering analysts | 10 | 15 | 28 | 4 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — |
| Dividend StreakConsecutive years of raises | — | 0 | 0 | — |
| Dividend / ShareAnnual DPS | — | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | +0.5% | +11.3% |
ALKS leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). SEER leads in 1 (Valuation Metrics). 2 tied.
QTRX vs DBVT vs ALKS vs SEER: Key Questions Answered
8 questions · data-driven answers · updated daily
01Is QTRX or DBVT or ALKS or SEER a better buy right now?
For growth investors, Quanterix Corporation (QTRX) is the stronger pick with 2.
6% revenue growth year-over-year, versus -8. 1% for Seer, Inc. (SEER). Alkermes plc (ALKS) offers the better valuation at 24. 8x trailing P/E, making it the more compelling value choice. Analysts rate Quanterix Corporation (QTRX) a "Buy" — based on 10 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — QTRX or DBVT or ALKS or SEER?
Over the past 5 years, Alkermes plc (ALKS) delivered a total return of +60.
9%, compared to -95. 1% for Quanterix Corporation (QTRX). Over 10 years, the gap is even starker: ALKS returned -11. 0% versus SEER's -96. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — QTRX or DBVT or ALKS or SEER?
By beta (market sensitivity over 5 years), Seer, Inc.
(SEER) is the lower-risk stock at 0. 84β versus Quanterix Corporation's 1. 98β — meaning QTRX is approximately 135% more volatile than SEER relative to the S&P 500. On balance sheet safety, Alkermes plc (ALKS) carries a lower debt/equity ratio of 4% versus 13% for DBV Technologies S. A. — giving it more financial flexibility in a downturn.
04Which is growing faster — QTRX or DBVT or ALKS or SEER?
By revenue growth (latest reported year), Quanterix Corporation (QTRX) is pulling ahead at 2.
6% versus -8. 1% for Seer, Inc. (SEER). On earnings-per-share growth, the picture is similar: Seer, Inc. grew EPS -3. 0% year-over-year, compared to -347. 5% for DBV Technologies S. A.. Over a 3-year CAGR, SEER leads at 29. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — QTRX or DBVT or ALKS or SEER?
Alkermes plc (ALKS) is the more profitable company, earning 16.
4% net margin versus -620. 9% for Seer, Inc. — meaning it keeps 16. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ALKS leads at 17. 2% versus -717. 7% for SEER. At the gross margin level — before operating expenses — ALKS leads at 86. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Which pays a better dividend — QTRX or DBVT or ALKS or SEER?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
07Is QTRX or DBVT or ALKS or SEER better for a retirement portfolio?
For long-horizon retirement investors, Seer, Inc.
(SEER) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 84)). Quanterix Corporation (QTRX) carries a higher beta of 1. 98 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (SEER: -96. 7%, QTRX: -84. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
08What are the main differences between QTRX and DBVT and ALKS and SEER?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.